Flemish Institute for Biotechnology Testing Leukine on COVID-19 Patients Lungs in Hopes to Prevent Dangerous ICU Cases

Flemish Institute for Biotechnology Testing Leukine on COVID-19 Patients Lungs in Hopes to Prevent Dangerous ICU Cases

Investigators at the university hospital of Ghent and the Flemish Institute for Biotechnology (VIB) have commenced a clinical trial assessing the drug Leukine to identify if it could be useful in the treatment of COVID-19 patients. The Belgium-based investigators hope...

Pin It on Pinterest